Evaluation of Safety and Efficacy of a Digital Therapeutic Device to Improve Strength in Sarcopenia (Sarc-DTx)

Recruiting N/A Interventional Study
Sarcopenia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 85
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
130 (estimated)
Sponsor
Exosystems · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This clinical trial aims to demonstrate that the use of a digital therapeutic device (exoDTx) in patients with sarcopenia is superior to self-exercise in terms of muscle strength improvement and safety.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria * Individuals diagnosed with sarcopenia according to both the European Working Group on Sarcopenia in Older People (EWGSOP) criteria and the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria * Individuals with reduced muscle strength, defined as at least one of the fol…
Contacts

Sangui Choi, CPO

+82-10-3028-7759

tkddml30@exosystems.io

CONTACT

Eun Ji Lee, AP

+82-10-5205-8976

eunjilv7@gmail.com

CONTACT